european medicines agency ema updates general guidelines on development of medicinal products for major depressive disorder mdd to include a section on psychedelic therapy 244127

European Medicines Agency (EMA) updates general guidelines on development of medicinal products for Major Depressive Disorder (MDD) to include a section on psychedelic therapy.

 

Psychedelic Health provide the update With up to two-thirds of MDD patients not responding to current therapies, there is an urgent need for new and innovative treatments.  The area of psychedelic research has in recent years produced increasing clinical evidence that points towards these therapies as being potentially efficacious treatments for the condition. The guidelines 

​ Psychedelic Health provide the update With up to two-thirds of MDD patients not responding to current therapies, there is an urgent need for new and innovative treatments.  The area of psychedelic research has in recent years produced increasing clinical evidence that points towards these therapies as being potentially efficacious treatments for the condition. The guidelines […] 

Read More 

Cannabis Law Report 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.